GHRP-4

GHS compounds stimulate ghrelin signaling, which increases hunger. This typically resolves within hours of injection. Manage by timing injections away from meals or eating small, protein-rich snacks.

Mild facial flushing or sensation of warmth may occur within 5-15 minutes of injection. Usually resolves within 30 minutes. No intervention required.

Local erythema or minor edema at the injection site may occur, particularly if sites are not rotated adequately. Prevent by rotating injection sites with each dose. Apply ice if needed.

Mild headaches have been reported in some users, possibly related to rapid GH elevation. Usually self-resolving. Ensure adequate hydration.

Prolonged GH elevation may increase risk of carpal tunnel syndrome or exacerbate existing symptoms due to soft tissue expansion. Monitor for wrist pain or numbness. Discontinue if symptoms develop and seek medical evaluation.

Continuous daily dosing may lead to desensitization of GHS-R1a receptors, reducing GH secretion response. Manage by implementing cycling protocols (e.g., 5 days on, 2 days off) or varying injection timing.

Some users report mild joint or muscle discomfort, possibly related to increased GH and IGF-1 levels. Usually mild and self-resolving. Ensure adequate rest and recovery.

Elevated GH may increase water retention, leading to mild bloating or weight gain. Typically resolves with adequate hydration and electrolyte balance.

GH has counter-insulin effects; elevated GH may impair glucose tolerance in susceptible individuals. Monitor blood glucose if you have diabetes or metabolic risk factors. Discontinue if significant hyperglycemia develops.

Transient dizziness may occur shortly after injection. Sit or lie down if this occurs. Usually resolves within minutes.